Michael Barbella, Managing Editor02.18.23
MPO website visitors showed their love this past week for four Titan Medical executives who were laid off from the financially troubled company.
Tammy Carrea, vice president of quality and regulatory affairs; Kristen Galfetti, vice president of investor relations and corporate communications; Eric Heinz, vice president of market and corporate development; and Chris Seibert, vice president of upstream marketing became the latest victims of Titan's year-long struggle to remain solvent. The four are not totally severing ties, though: They have agreed to remain with the company as independent consultants amid Titan’s ongoing strategic review process.
Titan's latest round of pink slips—announced just days after 48 employees were laid off—occurred in conjunction with another Nasdaq warning about its stock price. The company has been in trouble with Nasdaq for more than a year because its shares have not risen above the required $1 minimum for 30 consecutive business days at the end of 2021. Titan’s stock reached an all-time low of just $0.13 per share on Valentine's Day.
Digital wayfarers also were fond of Sunrise's most recent FDA clearance and Vizient's partnership with SafeSource Direct LLC. The former received clearance for its second-generation at-home sleep apnea test that uses AI to help diagnose obstructive sleep apnea and sleep-related breathing disorders.Vizient, meanwhile, won hearts for working with SafeSource too boost the nation's nitrile glove supply.
In addition to the Titan Medical layoffs, FDA clearance and U.S. glove supply news, cybervisitors also expressed a soft spot for two online exclusives. One deals with the benefits of implementing a robust workflow solution to address medical device manufacturing changes, while the other detailed survey results commissioned by Molex and Avnet on diagnostic wearables and the ways in which this industry segment is evolving.
Tammy Carrea, vice president of quality and regulatory affairs; Kristen Galfetti, vice president of investor relations and corporate communications; Eric Heinz, vice president of market and corporate development; and Chris Seibert, vice president of upstream marketing became the latest victims of Titan's year-long struggle to remain solvent. The four are not totally severing ties, though: They have agreed to remain with the company as independent consultants amid Titan’s ongoing strategic review process.
Titan's latest round of pink slips—announced just days after 48 employees were laid off—occurred in conjunction with another Nasdaq warning about its stock price. The company has been in trouble with Nasdaq for more than a year because its shares have not risen above the required $1 minimum for 30 consecutive business days at the end of 2021. Titan’s stock reached an all-time low of just $0.13 per share on Valentine's Day.
Digital wayfarers also were fond of Sunrise's most recent FDA clearance and Vizient's partnership with SafeSource Direct LLC. The former received clearance for its second-generation at-home sleep apnea test that uses AI to help diagnose obstructive sleep apnea and sleep-related breathing disorders.Vizient, meanwhile, won hearts for working with SafeSource too boost the nation's nitrile glove supply.
In addition to the Titan Medical layoffs, FDA clearance and U.S. glove supply news, cybervisitors also expressed a soft spot for two online exclusives. One deals with the benefits of implementing a robust workflow solution to address medical device manufacturing changes, while the other detailed survey results commissioned by Molex and Avnet on diagnostic wearables and the ways in which this industry segment is evolving.